News

Cardio Ox investigation Astronaut Oxidative Stress Cardiovascular Health

The heart of an astronaut is a much-studied thing. Scientists have analyzed its blood flow, rhythms, atrophy and, through journal studies, even matters of the heart. 

July 30, 2014 — Regado Biosciences announced earlier this month it has voluntarily paused enrollment in its REGULATE-PCI trial, which was testing the safety and effectiveness of its Revolixys...

Biotronik BIOLUX 4Ever Clinical Trial Pulsar-18 SES Passeo-18 Lux DRB PAD Cath

Biotronik announced that the first patient has been enrolled in the investigator-initiated BIOLUX 4EVER trial. 

Robert Smith, a cardiologist at Saint Francis Hospital and Medical Center in Hartford, Conn., released the results of his retrospective study designed to compare single in-office automated blood...

EndoPAT diagnostic device

Data from a new study indicate that the results of an FDA-approved test for endothelial (arterial) function significantly correlated with near-future cardiovascular events, of which the majority...

heart attacks, women's health

A new look at hospital data shows women have longer hospital stays and are more likely than men to die in the hospital after a heart attack.

stentys, stent, self-apposing stent

Stentys has announced the publication of an article in the Journal of the American College of Cardiology (JACC) entitled, "Causes of Early Stent Thrombosis in Patients Presenting with Acute...

July 18, 2014 — Avinger announced that John Pigott, M.D., of Jobst Vascular Institute, Toledo, Ohio, enrolled the first patient in the VISION trial, a global investigational device exemption (IDE...

Surgical aortic valve replacement generally improves patients’ symptoms and prolongs survival. However, the perceived risk of surgical aortic valve replacement in patients over 80 may result in...

July 15, 2014 — Chelation treatments reduce cardiovascular events, such as heart attacks, and death in patients with diabetes but not in those who did not have diabetes, according to analyses of...

July 15 2014 — Researchers at the University of California, San Diego School of Medicine have documented the safety benefits of aortic stent grafts inserted during minimally invasive surgery to...

TeleRehab VersaCare 2.1 Windows 7 The ScottCare Corp. Cardiac Rehabilitation

The ScottCare Corp. announced the newest version of its multi-parameter telemetry solution, TeleRehab VersaCare 2.1, which is the industry’s first Windows 7-based cardiopulmonary rehab telemetry...

Medtronic Reveal XT ICM CRYSTAL AF Clinical Trial Atrial Fibrillation

Medtronic Inc. announced results from the CRYSTAL AF (CRYptogenic STroke And underLying Atrial Fibrillation) clinical trial, published in The New England Journal of Medicine. The trial found that...

OrbusNeich Patient Enrollment Completion REMEDEE Registry Combo Stent

OrbusNeich announced the completion of enrollment in the prospective, multicenter, all-comers REMEDEE Registry (Multicenter, Prospective, Clinical Outcomes After Deployment of the Abluminal...

Researchers have announced the results of a study that used a novel echocardiographic technique to detect and quantify damage to heart muscle even after an episode of mild cardiac injury from...

June 23, 2014 — Men who reported being sedentary, with low levels of physical activity, were at a significantly higher risk for heart failure than those who were more active, according to a Kaiser...

Cardiovascular Systems Inc. (CSI) announced that the first patient has been enrolled in its Coronary Orbital Atherectomy System Trial (COAST) trial.

UT Southwestern Medical Center Cardiac Diagnostics Hill Wang Clinical Study

Heart attack and stroke are among the most serious threats to health. But novel research at University of Texas Southwestern Medical Center has linked two major biological processes that occur at...

Mast Therapeutics Failure MST-188 Clinical Study Pharmaceuticals

Mast Therapeutics Inc. announced that, in a placebo-controlled, nonclinical model of chronic heart failure, MST-188 demonstrated a statistically significant improvement in numerous parameters of...

June 10, 2014 — Ariad Pharmaceuticals Inc. and Medinol Ltd. earlier this year initiated two registration trials of Medinol’s NIRsupreme ridaforolimus-eluting coronary stent system incorporating...